{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:41:44Z","timestamp":1792190504153,"version":"4.4.0"},"reference-count":111,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>In the last few years there has been an increased appreciation that pain perception in rheumatic and musculoskeletal diseases (RMDs) has several mechanisms which include nociceptive, inflammatory, nociplastic and neuropathic components. Studies in specific patient groups have also demonstrated that the pain experienced by people with specific diagnoses can present with distinctive components over time. For example, the pain observed in rheumatoid arthritis has been widely accepted to be caused by the activation of nociceptors, potentiated by the release of inflammatory mediators, including prostaglandins, leukotrienes and cytokine networks in the joint environment. However, people with RA may also experience nociplastic and neuropathic pain components, particularly when treatments with disease modifying anti-rheumatic drugs (DMARDs) have been implemented and are insufficient to control pain symptoms. In other RMDs, the concept of pain sensitisation or nociplastic pain in driving ongoing pain symptoms e.g. osteoarthritis and fibromyalgia, is becoming increasingly recognised. In this review, we explore the hypothesis that pain has distinct modalities based on clinical, pathophysiological, imaging and genetic factors. The concept of pain stratification in RMD is explored and implications for future management are also discussed.<\/jats:p>","DOI":"10.3389\/fpain.2024.1362757","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T04:36:30Z","timestamp":1709786190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Can we achieve pain stratification in musculoskeletal conditions? Implications for clinical practice"],"prefix":"10.3389","volume":"5","author":[{"given":"Nidhi","family":"Sofat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lambarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e010364","DOI":"10.1136\/bmjopen-2015-010364","article-title":"Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies","volume":"6","author":"Fayaz","year":"2016","journal-title":"BMJ Open"},{"key":"B2","author":"Price","year":"2012"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1097\/j.pain.0000000000001939","article-title":"The revised IASP definition of pain: concepts, challenges, and compromises","volume":"161","author":"Raja","year":"2020","journal-title":"Pain"},{"key":"B4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","article-title":"The IASP classification of chronic pain for ICD-11: chronic primary pain","volume":"160","author":"Nicholas","year":"2019","journal-title":"Pain"},{"key":"B5","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1037\/0033-2909.133.4.581","article-title":"The biopsychosocial approach to chronic pain: scientific advances and future directions","volume":"133","author":"Gatchel","year":"2007","journal-title":"Psychol Bull"},{"key":"B6","first-page":"2","article-title":"Pain management in rheumatology research, training, and practice","volume":"35","author":"Borenstein","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1172\/JCI45178","article-title":"What is this thing called pain","volume":"120","author":"Woolf","year":"2010","journal-title":"J Clin Invest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1172\/JCI43195","article-title":"The discovery and development of analgesics: new mechanisms, new modalities","volume":"120","author":"Burgess","year":"2010","journal-title":"J Clin Invest"},{"key":"B9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/AJP.0b013e3181773b7f","article-title":"The pitfalls of profoundly effective analgesic therapies","volume":"24","author":"Clark","year":"2008","journal-title":"Clin J Pain"},{"key":"B10","first-page":"S102","article-title":"The contribution of rudolf virchow to the concept of inflammation: what is still of importance?","volume":"19","author":"Heidland","year":"2006","journal-title":"J Nephrol"},{"key":"B11","first-page":"3","volume-title":"Peripheral mechanisms of cutaneous nociception. Wall and Melzack\u2019s Textbook of Pain","author":"Meyer","year":"2008"},{"key":"B12","doi-asserted-by":"publisher","first-page":"eabj9954","DOI":"10.1126\/scitranslmed.abj9954","article-title":"Acute inflammatory response via neutrophil activation protects against the development of chronic pain","volume":"14","author":"Parisien","year":"2022","journal-title":"Sci Translational Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1097\/j.pain.0000000000002287","article-title":"Classification of chronic pain for the international classification of diseases (ICD-11): results of the 2017 international world health organization field testing","volume":"163","author":"Barke","year":"2022","journal-title":"Pain"},{"key":"B14","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s13075-014-0470-8","article-title":"Nociceptive neurons detect cytokines in arthritis","volume":"16","author":"Schaible","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.pain.2010.11.014","article-title":"TNF-alpha contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2","volume":"152","author":"Zhang","year":"2011","journal-title":"Pain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1097\/j.pain.0000000000002726","article-title":"Omics approaches to discover pathophysiological pathways contributing to human pain","volume":"163","author":"Diatchenko","year":"2022","journal-title":"Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"422","DOI":"10.55563\/clinexprheumatol\/0c7d6v","article-title":"Fibromyalgia in women: somatisation or stress-evoked, sex-dimorphic neuropathic pain?","volume":"39","author":"Martinez-Lavin","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"B18","year":"2019"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","article-title":"Nociplastic pain: towards an understanding of prevalent pain conditions","volume":"397","author":"Fitzcharles","year":"2021","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S2665-9913(21)00032-1","article-title":"Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine","volume":"3","author":"Nijs","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.math.2009.12.001","article-title":"Recognition of central sensitization in patients with musculoskeletal pain: application of pain neurophysiology in manual therapy practice","volume":"15","author":"Nijs","year":"2010","journal-title":"Man Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2629","DOI":"10.1097\/j.pain.0000000000002324","article-title":"Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system","volume":"162","author":"Kosek","year":"2021","journal-title":"Pain"},{"key":"B23","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11926-002-0040-y","article-title":"Peripheral and central sensitization in musculoskeletal pain disorders: an experimental approach","volume":"4","author":"Graven-Nielsen","year":"2002","journal-title":"Curr Rheumatol Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/ACO.0b013e32833c348b","article-title":"Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states","volume":"23","author":"Yarnitsky","year":"2010","journal-title":"Curr Opin Anaesthesiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.pain.2008.06.025","article-title":"Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations","volume":"139","author":"Turk","year":"2008","journal-title":"Pain"},{"key":"B28","first-page":"129","article-title":"Pain assessment: global use of the brief pain inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Annals, Academy of Medicine, Singap"},{"key":"B29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5l: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","article-title":"The validity of the hospital anxiety and depression scale: an updated literature review","volume":"52","author":"Bjelland","year":"2002","journal-title":"J Psychosom Res"},{"key":"B31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3410\/M1-76","article-title":"Diagnosis and assessment of neuropathic pain","volume":"1","author":"May","year":"2009","journal-title":"F1000 Med Rep"},{"key":"B32","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/JPR.S69011","article-title":"Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting, 2014","volume":"7","author":"Ahmed","year":"2014","journal-title":"J Pain Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1000045","DOI":"10.1371\/journal.pmed.1000045","article-title":"Tools for assessing neuropathic pain","volume":"6","author":"Cruccu","year":"2009","journal-title":"PLoS Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"703138","DOI":"10.1155\/2012\/703138","article-title":"Quantitative sensory testing in painful hand osteoarthritis demonstrates features of peripheral sensitisation","author":"Wajed","year":"2012","journal-title":"Int J Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.1016\/S2665-9913(23)00094-2","article-title":"Pain in the joints and beyond; the challenge of rheumatoid arthritis","volume":"5","author":"Taylor","year":"2023","journal-title":"The Lancet Rheumatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.24932","article-title":"Brain involvement in rheumatoid arthritis: a magnetic resonance spectroscopy study","volume":"60","author":"Emmer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.drudis.2017.11.012","article-title":"The role of fMRI in drug development","volume":"23","author":"Carmichael","year":"2018","journal-title":"Drug Discov Today"},{"key":"B38","year":""},{"key":"B39","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1097\/00007632-200011150-00017","article-title":"The oswestry disability index","volume":"25","author":"Fairbank","year":"2000","journal-title":"Spine"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1097\/00007632-200012150-00006","article-title":"The roland-morris disability questionnaire and the oswestry disability questionnaire","volume":"25","author":"Roland","year":"2000","journal-title":"Spine"},{"key":"B41","first-page":"603","article-title":"Mechanisms for joint pain in rheumatoid arthritis (RA): from cytokines to central sensitisation","volume-title":"Curr Osteoporosis Rep","author":"Zhang","year":"2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"R82","DOI":"10.1186\/ar2716","article-title":"Nerve growth factor and receptor expression in rheumatoid arthritis and spondyloarthritis","volume":"11","author":"Barthel","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B43","doi-asserted-by":"publisher","first-page":"CD013562","DOI":"10.1002\/14651858.CD013562","article-title":"Disease-modifying anti-rheumatic drugs for rheumatoid arthritis: a systematic review and network meta-analysis","volume":"3","author":"Hazlewood","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"CD008952","DOI":"10.1002\/14651858.CD008952.pub2","article-title":"Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity","volume":"10","author":"Marks","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.33326","article-title":"Structural changes of the brain in rheumatoid arthritis","volume":"64","author":"Wartolowska","year":"2012","journal-title":"Arthritis Rheum"},{"key":"B46","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/ejp.1140","article-title":"Assessment and manifestation of central sensitisation across different chronic pain conditions","volume":"22","author":"Arendt-Nielsen","year":"2018","journal-title":"Eur J Pain"},{"key":"B47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.33590\/emj\/21-00062","article-title":"Which biologic therapies to treat rheumatoid arthritis and when?","volume":"6","author":"Blundell","year":"2021","journal-title":"Eur Med J"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/bja\/87.1.3","article-title":"Mechanisms of inflammatory pain","volume":"87","author":"Kidd","year":"2001","journal-title":"Br J Anaesth"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008920.pub2","article-title":"Antidepressants for pain management in rheumatoid arthritis","volume":"11","author":"Richards","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B50","year":""},{"key":"B51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3389\/fnmol.2017.00349","article-title":"Mechanisms of osteoarthritic pain. Studies in humans and experimental models","volume":"10","author":"Eitner","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1136\/annrheumdis-2013-204191","article-title":"Multicenter osteoarthritis (MOST) study. Sensitivity and sensitisation in relation to pain severity in knee osteoarthritis: trait or state?","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.01016","article-title":"Biomarkers in painful symptomatic knee OA demonstrate that MRI assessed joint damage and type II collagen degradation products are linked to disease progression","volume":"13","author":"Sofat","year":"1016","journal-title":"Front Neurosci"},{"key":"B54","first-page":"79","article-title":"The role of centralised pain in osteoarthritis","volume":"35","author":"Clauw","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e001326","DOI":"10.1136\/rmdopen-2020-001326","article-title":"Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic","volume":"6","author":"Bailly","year":"2020","journal-title":"RMD Open"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/art.22995","article-title":"Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial","volume":"57","author":"Hurley","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa0901510","article-title":"Tanezumab for the treatment of pain from osteoarthritis of the knee","volume":"363","author":"Lane","year":"","journal-title":"N Engl J Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jama.2019.8044","article-title":"Effect of tanezumab on joint pain, physical function, and patient global assessment of osteoarthritis among patients with osteoarthritis of the hip or knee: a randomized clinical trial","volume":"322","author":"Schnitzer","year":"2019","journal-title":"JAMA"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1097\/j.pain.0000000000001625","article-title":"Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety","volume":"160","author":"Schmelz","year":"2019","journal-title":"Pain"},{"key":"B60","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.joca.2014.10.005","article-title":"Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies","volume":"23","author":"Hochberg","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"key":"B61","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1016\/S0140-6736(18)30480-X","article-title":"Underwood M; lancet low back pain series working group. What low back pain is and why we need to pay attention","volume":"391","author":"Hartvigsen","year":"2018","journal-title":"Lancet"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.12688\/f1000research.8105.2","article-title":"Mechanisms of low back pain: a guide for diagnosis and therapy","volume":"5","author":"Allegri","year":"2016","journal-title":"F1000Res"},{"key":"B63","year":""},{"key":"B64","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/bjsports-2018-099943","article-title":"High intensity exercise for 3 months reduces disease activity in axial spondyloarthritis (axSpA): a multicentre randomised trial of 100 patients","volume":"54","author":"Sveaas","year":"2020","journal-title":"Br J Sports Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"681640","DOI":"10.4061\/2011\/681640","article-title":"Benefits of exercise in rheumatoid arthritis","author":"Cooney","year":"2011","journal-title":"J Aging Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.31887\/DCNS.2018.20.1\/whauser","article-title":"Facts and myths pertaining to fibromyalgia","volume":"20","author":"H\u00e4user","year":"2018","journal-title":"Dialogues Clin Neurosci"},{"key":"B67","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/pmt-2018-0024","article-title":"Fibromyalgia: is it a neuropathic pain?","volume":"8","author":"Cheng","year":"2018","journal-title":"Pain Manag"},{"key":"B68","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.berh.2007.02.011","article-title":"Genetics of chronic pain states","volume":"21","author":"Buskila","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1126\/science.1060952","article-title":"Regional mu opioid receptor regulation of sensory and affective dimensions of pain","volume":"293","author":"Zubeieta","year":"2011","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pain.2006.09.022","article-title":"Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta-2 and beta-3 adrenergic receptors","volume":"128","author":"Nackley","year":"2007","journal-title":"Pain"},{"key":"B71","doi-asserted-by":"publisher","first-page":"103423","DOI":"10.1016\/j.autrev.2023.103423","article-title":"Residual pain in rheumatoid arthritis: is it a real problem?","volume":"22","author":"Sarzi-Puttini","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1080\/14397595.2017.1416940","article-title":"Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review","volume":"28","author":"Ishida","year":"2018","journal-title":"Modern Rheumatology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/BOR.0000000000000929","article-title":"Fibromyalgia and centralized pain in the rheumatoid arthritis patient","volume":"35","author":"Minhas","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR Definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B75","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR Revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"B77","doi-asserted-by":"publisher","first-page":"179","DOI":"10.18773\/austprescr.2017.056","article-title":"Treatment of fibromyalgia","volume":"40","author":"Kwiatek","year":"2017","journal-title":"Aust Prescr"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/j.pain.0000000000002910","article-title":"A systematic review of genome-wide association studies for pain, nociception, neuropathy, and pain treatment responses","volume":"164","author":"Li","year":"2023","journal-title":"Pain"},{"key":"B79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1192\/BJP.BP.108.063156","article-title":"Dissecting the phenotype in genome-wide association studies of psychiatric illness","volume":"195","author":"Craddock","year":"2009","journal-title":"Br J Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/S42003-020-1051-9","article-title":"Analysis of genetically independent phenotypes identifies shared genetic factors associated with chronic musculoskeletal pain conditions","volume":"3","author":"Tsepilov","year":"2020","journal-title":"Commun Biol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","article-title":"Do we need a third mechanistic descriptor for chronic pain states?","volume":"157","author":"Kosek","year":"2016","journal-title":"Pain"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/03007995.2018.1552042","article-title":"Current understanding of the mixed pain concept: a brief narrative review","volume":"35","author":"Freynhagen","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"B83","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/ejp.1902","article-title":"Different genes may be involved in distal and local sensitization: a genome-wide gene-based association study and meta-analysis","volume":"26","author":"Kouraki","year":"2022","journal-title":"Eur J Pain"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e2136560","DOI":"10.1001\/JAMANETWORKOPEN.2021.36560","article-title":"Association of genetic variant at chromosome 12q23.1 with neuropathic pain susceptibility","volume":"4","author":"Veluchamy","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e1007601","DOI":"10.1371\/JOURNAL.PGEN.1007601","article-title":"Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain","volume":"14","author":"Suri","year":"2018","journal-title":"PLoS Genet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1009428","DOI":"10.1371\/JOURNAL.PGEN.1009428","article-title":"Sex-stratified genome-wide association study of multisite chronic pain in UK Biobank","volume":"17","author":"Johnston","year":"2021","journal-title":"PLoS Genet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"e1008164","DOI":"10.1371\/JOURNAL.PGEN.1008164","article-title":"Genome-wide association study of multisite chronic pain in UK Biobank","volume":"15","author":"Johnston","year":"2019","journal-title":"PLoS Genet"},{"key":"B88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1136\/ANNRHEUMDIS-2012-201742","article-title":"Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region","volume":"72","author":"Peters","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/J.PAIN.2014.02.016","article-title":"Genome-wide analysis of single nucleotide polymorphisms and copy number variants in fibromyalgia suggest a role for the central nervous system","volume":"155","author":"Docampo","year":"2014","journal-title":"Pain"},{"key":"B90","doi-asserted-by":"publisher","first-page":"e0163877","DOI":"10.1371\/JOURNAL.PONE.0163877","article-title":"Genome-Wide meta-analysis of sciatica in Finnish population","volume":"11","author":"Lemmel\u00e4","year":"2016","journal-title":"PLoS One"},{"key":"B91","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/S42003-019-0568-2","article-title":"Genome-wide association study of knee pain identifies associations with GDF5 and COL27A1 in UK biobank","volume":"2","author":"Meng","year":"2019","journal-title":"Commun Biol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/S00439-022-02507-Z","article-title":"Investigating the shared genetic architecture and causal relationship between pain and neuropsychiatric disorders","volume":"142","author":"Chen","year":"2023","journal-title":"Hum Genet"},{"key":"B93","doi-asserted-by":"publisher","first-page":"E1018","DOI":"10.1097\/PR9.0000000000001018","article-title":"Brain-specific genes contribute to chronic but not to acute back pain","volume":"7","author":"Bortsov A","year":"2022","journal-title":"Pain Rep"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1097\/J.PAIN.000000000000256896","article-title":"Genome-wide association study of pain sensitivity assessed by questionnaire and the cold pressor test","volume":"163","author":"Fontanillas","year":"2022","journal-title":"Pain"},{"key":"B95","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-64922-1_597","article-title":"Pain assessment","author":"Dydyk","year":"2023","journal-title":"Fundam Pain Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/NRRHEUM.2013.4398","article-title":"The phenotypic and genetic signatures of common musculoskeletal pain conditions","volume":"9","author":"Diatchenko","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/J.NEUROSCIENCE.2016.04.04199","article-title":"Genetic predictors of human chronic pain conditions","volume":"338","author":"Zorina-Lichtenwalter","year":"2016","journal-title":"Neuroscience"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1101\/2023.06.27.23291959100","article-title":"Chronic overlapping pain conditions and nociplastic pain","volume":"2023","author":"Johnston","year":"2023","journal-title":"medRxiv"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1177\/10600280211003875","article-title":"Pharmacogenomics in pain management: a review of relevant gene-drug associations and clinical considerations","volume":"55","author":"Brandl","year":"2021","journal-title":"Ann Pharmacother"},{"key":"B100","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/cpt.2149","article-title":"Clinical pharmacogenetics implementation consortium guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy","volume":"110","author":"Crews","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"B101","year":""},{"key":"B102","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR Revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B103","year":""},{"key":"B104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/annrheumdis-2018-213826","article-title":"2018 Update of the EULAR recommendations for the management of hand osteoarthritis","volume":"78","author":"Kloppenburg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B105","year":""},{"key":"B106","year":""},{"key":"B107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s42238-020-00024-2","article-title":"Cannabinoids for fibromyalgia pain: a critical review of recent studies (2015\u20132019)","volume":"2","author":"Cameron","year":"2020","journal-title":"J Cannabis Res"},{"key":"B108","doi-asserted-by":"publisher","first-page":"108216","DOI":"10.1016\/j.pharmthera.2022.108216","article-title":"Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research","volume":"240","author":"Bourke","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B109","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.lanepe.2023.100777","article-title":"Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial","volume":"35","author":"Pramhas","year":"2023","journal-title":"The Lancet Regional Health\u2014Europe"},{"key":"B110","doi-asserted-by":"publisher","first-page":"100343","DOI":"10.1016\/j.ocarto.2023.100343","article-title":"The effect of pentosan polysulfate sodium for improving dyslipidaemia and knee pain in people with knee osteoarthritis: a pilot study","volume":"5","author":"Liu","year":"2023","journal-title":"Osteoarthr Cartil Open"},{"key":"B111","year":""}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2024.1362757\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T04:36:39Z","timestamp":1709786199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2024.1362757\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":111,"alternative-id":["10.3389\/fpain.2024.1362757"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2024.1362757","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"article-number":"1362757"}}